Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
In patients with Duchenne Muscular Dystrophy who have an exon 51 mutation, do you treat with both prednisone and Eteplirsen?
What are common side effects to look out for with Eteplirsen?
Related Questions
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
Do you always biopsy patients who present with classic skin findings of dermatomyositis?
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
When do you consider ultrahigh-dose methylcobalamin injections for ALS?
How do you decide if patients who have a multifocal demyelinating polyneuropathy would benefit from surgical treatment of carpal tunnel syndrome?
How do you use serum IgG levels when treating with FcRN inhibitors?
How does lack of success of rituximab treatment affect your decision to trial anti-CD19 therapies like inebilizumab?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
How do you approach selecting optimal muscle biopsy site when evaluating a patient for suspected inflammatory myopathy?
What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?